OneAscent Financial Services’s Collegium Pharmaceutical COLL Stock Holding History

OneAscent Financial Services’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11,872	Closed	-$210K	–	205
2022 Q2	$210K	Sell	11,872 -205	-2%	-$3.45K	0.1%	200
2022 Q1	$246K	Buy	12,077 +303	+3%	+$5.72K	0.18%	103
2021 Q4	$220K	Buy	11,774 +612	+5%	+$11.9K	0.42%	111
2021 Q3	$220K	Buy	+11,162	New	+$241K	0.29%	81
2021 Q1	$201K	Buy	+8,477	New	+$201K	0.2%	138
2020 Q4	–	Sell	-16,497	Closed	-$343K	–	139
2020 Q3	$343K	Buy	16,497 +4,659	+39%	+$84.1K	0.18%	121
2020 Q2	$207K	Buy	11,838 +715	+6%	+$14K	0.14%	160
2020 Q1	$182K	Sell	11,123 -9,583	-46%	-$198K	0.14%	135
2019 Q4	$426K	Buy	+20,706	New	+$345K	0.24%	72
2019 Q3	–	Sell	-20,888	Closed	-$275K	–	56
2019 Q2	$275K	Buy	+20,888	New	+$279K	0.19%	127

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OneAscent Financial Services's COLL Position: Q3 2022 in Review

OneAscent Financial Services sold out of Collegium Pharmaceutical (COLL) in Q3 2022, closing a stake of 11,872 shares — an estimated $210K sold.

OneAscent Financial Services first reported a position in COLL in Q2 2019 and held it in 10 quarters. The position peaked at $426K in Q4 2019. 168 funds tracked by Wall St. Rank hold COLL as of Q3 2022.

OneAscent Financial Services reported no remaining Collegium Pharmaceutical position as of Q3 2022 after selling out during the quarter.
OneAscent Financial Services sold 11,872 Collegium Pharmaceutical shares in Q3 2022, an estimated $210K.
OneAscent Financial Services first reported a position in Collegium Pharmaceutical in Q2 2019 and held it in 10 quarters.
OneAscent Financial Services's Collegium Pharmaceutical position peaked at $426K in Q4 2019.
168 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2022.

Based on OneAscent Financial Services's 13F filing for Q3 2022, filed 2 Nov 2022.